217) sions, the WHO recommends classifying the disease as dengue with or without warning |
218) aturally occurring infectious respiratory disease, as reported in the literature. |
219) to understanding the genetic basis of the disease, as well as detecting at-risk indi |
220) ain etiological agent of aspergillosis, a disease characterized by a noninvasive pro |
221) lized gastric amyloidosis (LGA) is a rare disease characterized by abnormal extracel |
222) SLE is a clinically heterogeneous disease characterized by an unpredictable |
223) rtension (PAH) is a rare and chronic lung disease characterized by progressive occlu |
224) phic Lateral Sclerosis is a neuromuscular disease characterized by the progressive d |
225) hypertension (PAH) is a devastating lung disease characterized by the progressive o |
226) e, a quality deemed essential for chronic disease management and health promotion. |
227) cognized as an essential end point in the disease management of chronic conditions s |
228) nt-facing apps supporting promote chronic disease management. |
229) ing, informed patient, collaboration, and disease management. |
230) ss the quality of mobile apps for chronic disease management. |
231) at can aid in tumor monitoring throughout disease management. |
232) ls paralleled several indices of COVID-19 disease severity (e.g., kidney dysfunction |
233) ailable noninvasive markers for assessing disease severity and mortality risk in pul |
234) standing of host determinants that impact disease severity and offer potential thera |
235) ffer from high-intensity inflammation and disease severity than the female populatio |
236) itis severity, we asked if Ket/Xyl affect disease severity. |
237) contracting COVID-19, taking into account disease severity. |
238) Background: Parkinson's Disease (PD) is a chronic neurodegenerativ |
239) ials in five individuals with Parkinson's disease (PD) for up to 15 months after imp |
240) Parkinson's disease (PD) is a significant cause of dis |
241) Parkinson's disease (PD) is a significant cause of dis |
242) entified correlations between Parkinson's disease (PD) risk and lifestyle factors. |
243) understand the role of gut microbiota in disease pathogenesis and therapeutic targe |
244) revealed or supported key discoveries in disease pathogenesis and therapy developme |
245) These factors seem to contribute to disease pathogenesis before the onset of c |
246) nding the mechanism underlying SARS-CoV-2 disease pathogenesis remains crucial for t |
247) rs in development, brain homeostasis, and disease pathogenesis. |
248) SLE patients with high disease activity had increased concentrati |
249) use of pregnancy registers and validated disease activity measurement tools for pre |
|